Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03871348
Title A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications

melanoma

Advanced Solid Tumor

lymphoma

skin squamous cell carcinoma

head and neck squamous cell carcinoma

Therapies

SAR441000

Cemiplimab + SAR441000

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Investigational Site Number :8400001 Recruiting Fairway Kansas 66205 United States Details
Investigational Site Number :8400003 Completed Boston Massachusetts 02115 United States Details
Investigational Site Number :8400007 Recruiting Cleveland Ohio 44195 United States Details
Investigational Site Number :8400002 Terminated Houston Texas 77030 United States Details
Investigational Site Number :0560001 Recruiting Bruxelles 1200 Belgium Details
Investigational Site Number :0560003 Recruiting Gent 9000 Belgium Details
Investigational Site Number :0560002 Recruiting Leuven 3000 Belgium Details
Investigational Site Number :2500004 Recruiting Marseille 13385 France Details
Investigational Site Number :2500002 Recruiting Paris 75010 France Details
Investigational Site Number :2500001 Recruiting Villejuif 94800 France Details
Investigational Site Number :2760005 Recruiting Hamburg 20246 Germany Details
Investigational Site Number :2760004 Recruiting Heidelberg 69120 Germany Details
Investigational Site Number :2760001 Recruiting Mainz 55131 Germany Details
Investigational Site Number :2760003 Recruiting Mannheim 68167 Germany Details
Investigational Site Number :2760006 Recruiting Tübingen 72076 Germany Details
Investigational Site Number :5280002 Active, not recruiting Nijmegen 6525GA Netherlands Details
Investigational Site Number :5280001 Completed Rotterdam 3015 CE Netherlands Details
Investigational Site Number :7240004 Recruiting Barcelona Barcelona [Barcelona] 08036 Spain Details
Investigational Site Number :7240001 Recruiting Pamplona Navarra 31008 Spain Details
Investigational Site Number :7240005 Recruiting Pamplona Navarra 31008 Spain Details
Investigational Site Number :7240002 Recruiting Valencia 46014 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field